Nevasic
Nevasic is #178 in Medical Paid in Japan and charting in 4 of 24 countries we track.
Updated 27 Sep 2026 · rankings refresh through the day
DeveloperDaval Ltd
CategoryMedical
Price299,000.00 IDR
Released
Rating★ 0.0 (0)
Version2.5
Age rating4+
First seen by us
25 Sep 2026
Installs (est.)1k+ worldwide
Rating
0.0 ★
0 ratings
Measured
Best rank now
#178
Measured
Nevasic on the App Store
App details
App ID
349098250
Publisher
DAVAL Ltd
Minimum OS
iOS 11.4+
Content rating
4+
Languages
1
EN
Size
290 MB
Nevasic downloads
Worldwide, per day, and installs to date. The band is open; the exact number is free with an account.
How this is calculated
Apple publishes no download counts. iPhone downloads come from chart positions and daily rating growth per country, calibrated on Google Play install counts; lifetime installs from ratings worldwide × installs per rating. Confidence is the chance the real number is within half to double ours.
Where Nevasic's downloads come from Modelled
Last 30 days: organic search, browsing the store, features and paid ads.
Active users
All platforms, worldwide. Free with an account.
Stickiness (DAU / MAU)
how many monthly users open it on a given day
How this is calculated
Monthly users come from lifetime installs across every store, fitted on monthly active user figures companies publish; daily users = monthly × the typical daily/monthly ratio for the category. Confidence is the chance the real number is within half to double ours.
Where it ranks now
Every top chart it appears in across 24 countries.
| Country | Charts | Rank |
|---|---|---|
| MedicalPaid | #178 | |
| MedicalPaid | #113 | |
| MedicalPaid | #70 | |
| MedicalPaid | #146 |
Apps near Nevasic on the chart
Medical Paid, around #178.
Ratings
App Store, worldwide.
Rating
0.0 ★
0 ratings
Measured
Ratings
0
Measured
About Nevasic
The Nevasic programme is effective for a wide range of conditions- whether you suffer from pregnancy sickness, travel sickness or sickness related to excesses, medical conditions and prescribed drugs.
Nevasic is a medical audio programme which stabilises the balance receptors in the inner ear in order to provide relief from nausea and sickness.
Nevasic delivers precisely engineered stabilising audio pulses and frequencies, presented in a jacket of music, to make consumption easy.
- - - - - - - - - -
Clinical trial - Motion sickness
The MRC Spatial Disorientation Group, Imperial College School of Medicine, London ran a full clinical trial under the branded of TravelWell.
The trial proved conclusively that the programme is highly effective in combating the symptoms of nausea and vomiting associated with motion sickness.
The report from the trial is lodged with PubMed and available via the National Library of Medicine (USA).
- - - - - - - - - -
NHS study - Morning sickness
Nevasic was studied by the UK NHS under the branded name of MorningWell.
The study was commissioned by;
Mr M J Heard FRCOG
Department of Obstetrics and Gynaecology
Royal Hampshire County Hospital
Winchester, UK.
Study Manager;
Midwife Mrs Lynne Mayo - SRN, SCM, - Andover NHS Birth Centre.
NHS research data.
A National Health Service (NHS) Study showed 9 out of 10 pregnant women experienced a reduction or elimination of their symptoms of nausea & vomiting in morning sickness by using Nevasic branded as MorningWell.
- - - - - - - - - -
Clinical Trial - Cancer patients
A clinical trial has been completed by Manchester University with mastectomy patients and the results were encouraging enough for a nationwide clinical trial to be requested by the UK institutes for research. This will be completed as soon as we can raise the required funding.
- - - - - - - - - -
Nevasic is a registered class 1 Medical Device in the UK and the USA. It is also registered by the Australian Medical Devices Listing Section (Conformity Assessment Branch) as an exempt product under the Therapeutic Goods Act.
Reviews:
Testimonial from USA customer:
If all I have to do is commit to less than 30 minutes every 3-4 days to listen to soothing music in order to not be sick -- well, who wouldn't do that?
The program definitely works, and I have told many of my friends about it so they won't have to suffer as I was before I found Nevasic. You were right in your initial email that it would take a few days to really work. Although I did have some relief the very first time I listened to it, it took a couple of days for the impact to really "stick." By the 4th day, though, I was able to not only eat to nourish the new life inside me, but I was able to get down on the floor to play w/ my 3 year old -- which I hadn't been able to do for several weeks. For that alone, I thank you!! (As would he, if he knew your program was the reason he was finally able to play with mommy again.) :o)
I c
Nevasic is a medical audio programme which stabilises the balance receptors in the inner ear in order to provide relief from nausea and sickness.
Nevasic delivers precisely engineered stabilising audio pulses and frequencies, presented in a jacket of music, to make consumption easy.
- - - - - - - - - -
Clinical trial - Motion sickness
The MRC Spatial Disorientation Group, Imperial College School of Medicine, London ran a full clinical trial under the branded of TravelWell.
The trial proved conclusively that the programme is highly effective in combating the symptoms of nausea and vomiting associated with motion sickness.
The report from the trial is lodged with PubMed and available via the National Library of Medicine (USA).
- - - - - - - - - -
NHS study - Morning sickness
Nevasic was studied by the UK NHS under the branded name of MorningWell.
The study was commissioned by;
Mr M J Heard FRCOG
Department of Obstetrics and Gynaecology
Royal Hampshire County Hospital
Winchester, UK.
Study Manager;
Midwife Mrs Lynne Mayo - SRN, SCM, - Andover NHS Birth Centre.
NHS research data.
A National Health Service (NHS) Study showed 9 out of 10 pregnant women experienced a reduction or elimination of their symptoms of nausea & vomiting in morning sickness by using Nevasic branded as MorningWell.
- - - - - - - - - -
Clinical Trial - Cancer patients
A clinical trial has been completed by Manchester University with mastectomy patients and the results were encouraging enough for a nationwide clinical trial to be requested by the UK institutes for research. This will be completed as soon as we can raise the required funding.
- - - - - - - - - -
Nevasic is a registered class 1 Medical Device in the UK and the USA. It is also registered by the Australian Medical Devices Listing Section (Conformity Assessment Branch) as an exempt product under the Therapeutic Goods Act.
Reviews:
Testimonial from USA customer:
If all I have to do is commit to less than 30 minutes every 3-4 days to listen to soothing music in order to not be sick -- well, who wouldn't do that?
The program definitely works, and I have told many of my friends about it so they won't have to suffer as I was before I found Nevasic. You were right in your initial email that it would take a few days to really work. Although I did have some relief the very first time I listened to it, it took a couple of days for the impact to really "stick." By the 4th day, though, I was able to not only eat to nourish the new life inside me, but I was able to get down on the floor to play w/ my 3 year old -- which I hadn't been able to do for several weeks. For that alone, I thank you!! (As would he, if he knew your program was the reason he was finally able to play with mommy again.) :o)
I c
Latest updates
2.5
This new version contains a fix to stop the audio breaking in background mode.